我们能否利用炎症细胞组进行宿主导疗法,对抗 Mycobacterium tuberculosis 感染?
Lilitha Cebani1, Nontobeko E Mvubu1
1School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.
International journal of molecular sciences
|August 10, 2024
概括
针对炎症体的宿主导疗法为结核病 (TB) 治疗提供了新的途径. 通过精确调节免疫反应,这些策略可以对抗Mycobacterium tuberculosis (M. tb) 感染和炎症.
科学领域:
- 免疫学和传染病的研究
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 由Mycobacterium tuberculosis (M. tb) 引起的结核病 (TB) 仍然是一个重大的全球卫生挑战,每年有数以百万计的新病例.
- 结核病免疫学的进步揭示了炎症体的关键作用,这些蛋白质复合体激活卡斯巴酶1以成熟IL-1β和IL-18,在宿主免疫反应中.
- 失调的炎酶激活会导致组织损伤和疾病进展,需要精确的控制机制.
研究的目的:
- 审查新型宿主导疗法 (HDT),调节结核病辅助治疗的炎症体通路.
- 探索精准医学方法的潜力,针对结核病中的个体炎症性反应.
- 突出治疗剂和用于控制结核病过度炎症的分子工具.
主要方法:
- 对结核病免疫学中炎症酶通路的当前文献的综述.
- 分析各种小分子和调节炎性酶激活的植物衍生物.
- 对严重结核病病例的基因沉默和淘汰技术的探索.
主要成果:
- 药用植物衍生物 (西利宾,安德罗格拉福利德,米切利奥利德) 和小分子 (OLT1177,INF39,CY-09,JJ002,Ac-YVAD-cmk,TAK-242,MCC950) 在调节炎性酶活性方面具有潜力.
- 规范性和非规范性炎症酶途径如果不适当调节,可能导致免疫疲劳和M. tb传播.
- 准炎症酶提供了一种控制过度炎症的策略,并可能克服药物耐药性.
结论:
- 调节炎性细胞路径代表了结核病的一个有前途的辅助宿主导治疗策略.
- 针对特定的炎症酶反应量身定制的精准医学方法可以提高结核病治疗的疗效.
- 对这些新型治疗干预措施的进一步研究对于对抗结核病,特别是耐药菌株至关重要.
相关概念视频
01:31Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
01:28Pulmonary Tuberculosis V
176
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
176
01:28Pulmonary Tuberculosis II
215
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
215
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
124
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
124
01:29Pulmonary Tuberculosis I
227
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
227